These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 14661977

  • 1. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin.
    Matsuka YV, Anderson ET, Milner-Fish T, Ooi P, Baker S.
    Biochemistry; 2003 Dec 16; 42(49):14643-52. PubMed ID: 14661977
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factor XIIIa mediated attachment of S. aureus fibronectin-binding protein A (FnbA) to fibrin: identification of Gln103 as a major cross-linking site.
    Severina E, Nunez L, Baker S, Matsuka YV.
    Biochemistry; 2006 Feb 14; 45(6):1870-80. PubMed ID: 16460033
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of blood coagulation factor XIIIa-mediated cross-linking between fibronectin and collagen by polyamines.
    Mosher DF, Schad PE, Kleinman HK.
    J Supramol Struct; 1979 Feb 14; 11(2):227-35. PubMed ID: 548650
    [Abstract] [Full Text] [Related]

  • 5. Staphylococcus aureus fibronectin-binding protein (FnBP)-mediated adherence to platelets, and aggregation of platelets induced by FnBPA but not by FnBPB.
    Heilmann C, Niemann S, Sinha B, Herrmann M, Kehrel BE, Peters G.
    J Infect Dis; 2004 Jul 15; 190(2):321-9. PubMed ID: 15216468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
    Park R, Ping L, Song J, Seo JY, Choi TY, Choi JR, Gorkun OV, Lord ST.
    Thromb Haemost; 2013 Feb 15; 109(2):199-206. PubMed ID: 23224113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures.
    Cui C, Wang S, Myneni VD, Hitomi K, Kaartinen MT.
    Bone; 2014 Feb 15; 59():127-38. PubMed ID: 24246248
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. von Willebrand factor-binding protein (vWbp)-activated factor XIII and transglutaminase 2 (TG2) promote cross-linking between FnBPA from Staphylococcus aureus and fibrinogen.
    Motta C, Pellegrini A, Camaione S, Geoghegan J, Speziale P, Barbieri G, Pietrocola G.
    Sci Rep; 2023 Jul 19; 13(1):11683. PubMed ID: 37468579
    [Abstract] [Full Text] [Related]

  • 17. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ, Shih MH, Tsai PJ.
    Thromb Haemost; 2005 Aug 19; 94(2):286-94. PubMed ID: 16113817
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.